SecBot SecBot
SC 13G ·Filed Nov 13, 2026

MDLN

Medline Inc.
NEUTRAL
Impact 3/10
Horizonimmediate Processed3d 6h ago SEC0001422848-26-000138
Passive investor 5%+ stake
Actionable Insight • Neutral

Monitor for any future 13D conversion by CRGI or other large holders, though the passive certification makes this unlikely. The combined disclosed passive ownership (CRGI 5.4% + GIC 8.49%) exceeds 13%, which could become relevant in any future control contest.

DirectionNeutral
Confidencehigh
Horizonimmediate

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Capital Research Global Investors filed a Schedule 13G disclosing a 5.4% passive stake in Medline Inc., representing 47,768,233 shares as of September 30, 2026. This is a new 5%+ disclosure by a major institutional investor, adding to the existing passive ownership by GIC (8.49% as of November 4). The filing confirms passive intent with no control-related purpose.

Key Financial Metrics

Stake
5.4%
Investor
Capital Research Global Investors
Investor Type
mutual fund

Key Facts

  • Capital Research Global Investors filed a new Schedule 13G disclosing beneficial ownership of 47,768,233 shares of Medline Inc.
  • The stake represents 5.4% of the 877,351,218 shares outstanding as of September 30, 2026.
  • The filing certifies passive investment intent under Rule 13d-1(b), with no purpose of changing or influencing control.
  • This is a new 5%+ disclosure; no prior 13G or 13D by this filer was found in the provided context.
  • GIC Private Ltd previously disclosed an 8.49% passive stake on November 4, 2026, down from 13.03% on October 30.

Financial Impact

Stake valued at approximately $3.0B based on $55.5B market cap and 5.4% ownership.

ownership concentration

Risk Factors

  • No material risks identified from this passive stake filing.
  • Document contains text addressed to automated readers (XML tags, EDGAR headers).

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
79% bullish (34 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G Filing (Primary)0001422848-26-000138
Document: 0001422848-26-000138-index.html0001422848-26-000138
Document: 0001422848-26-000138.txt0001422848-26-000138

Track record

30 reports on MDLN

Performance horizon

5 of 8 bullish or bearish reports moved the stock their way by T+5. Best: +17.95% at T+20 after the May 6, 2026 report. 5 of 8 went positive at some point.

Filters
  1. Nov 16, 2026today Press Release Bearish 5/10 Entry $36.40 Now $39.17 −7.61% settles Nov 23
  2. Nov 16, 2026today S-1 Neutral 4/10 Entry $39.05 Now $39.17 +0.31% settles Nov 23
  3. Nov 13, 20263d ago SC 13G Neutral 3/10 Viewing Entry $42.00 Now $39.17 −6.74% settles Nov 23
  4. Nov 13, 20263d ago 144 Neutral 2/10 Entry $42.00 Now $39.17 −6.74% settles Nov 23
  5. Nov 6, 202610d ago SC 13G/A Neutral 3/10 Entry $40.71 to $39.17 Now $39.17 −3.78% ▼ −3.78% −2.09% vs SPY
  6. Nov 4, 202612d ago 8-K Neutral 5/10 No price data
  7. Nov 4, 202612d ago Press Release Bullish 6/10 Entry $40.35 to $42.16 Now $39.17 −2.92% ▲ +4.49% +5.40% vs SPY
  8. Nov 2, 202614d ago Institutional Cluster Bearish 4/10 Entry $34.09 to $40.91 Now $39.17 −14.90% ▼ −20.01% −20.59% vs SPY
  9. Oct 30, 202617d ago SC 13G/A Neutral 3/10 Entry $32.12 to $39.64 Now $39.17 +21.95% ▲ +23.41% +26.12% vs SPY
  10. Oct 21, 202626d ago 8-K Bearish 6/10 Entry $34.88 to $32.00 Now $39.17 −12.30% ▲ +8.26% +8.96% vs SPY
Showing 10 of 30

US Market Status

Market Closed · Opens Wed (9h 38m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 13, 2026